The first non-invasive, adaptive neuromodulation digital treatment for migraine receives CE mark
Neurolief, a developer of digital therapeutics brain neuromodulation technology, has announced that it has received the CE mark for its Relivion non-invasive, adaptive digital treatment...
EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease
EVER Pharma, a company specialising in neurological diseases, announces the launch of its D-mine Pump. This portable micro infusion device recently received European CE...
Latest FDA caution for the use of off-label drugs in intrathecal drug delivery systems...
While the US Food and Drug Administration (FDA) has called for caution regarding the use of off-label medications administered intrathecally, pain management experts have...
Saluda Medical raises US$75 million equity financing from Boston Scientific and Redmile Group
Following the announcement of the debt financing with Medtronic, Saluda Medical has announced that it has secured US$75 million in equity financing from Boston...
(Visited 4,091 times, 6 visits today)
